Florida Oncology Partners (Tables) (FOP and FOPRE [Member])

6 Months Ended

Jun. 30, 2014

FOP and FOPRE [Member]

Schedule of Equity Method Investments [Line Items]

Summarized Financial Information

The following tables present the aggregation of summarized financial information of FOP and FOPRE:

FOP and FOPRE Condensed Income Statement Information

	Six Months Ended
	June 30,
	2014		2013
Patient revenue	$	1,235,000	$	1,469,000
Net income	$	48,000	$	81,000
USNC's equity in income of FOP   and FOPRE	$	10,000	$	16,000

	Three Months Ended
	June 30,
	2014		2013
Patient revenue	$	748,000	$	812,000
Net income	$	155,000	$	116,000
USNC's equity in income of FOP   and FOPRE	$	31,000	$	23,000

FOP and FOPRE Condensed Balance Sheet Information

	June 30,		December 31,
	2014		2013
Current assets	$	740,000	$	653,000
Noncurrent assets		5,396,000		5,795,000
Total assets	$	6,136,000	$	6,448,000
Current liabilities	$	989,000	$	893,000
Noncurrent liabilities		4,425,000		4,881,000
Equity		722,000		674,000
Total liabilities and equity	$	6,136,000	$	6,448,000